Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588348 · ClinicalTrials.gov registry record · Early Phase 1
Corticosteroid Effect on Achalasia Variant EGJOO
A Early Phase 1 study of Esophagogastric Junction Outflow Obstruction, sponsored by Baylor Research Institute.
- Active
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06588348 is a Early Phase 1 study of Esophagogastric Junction Outflow Obstruction that is active but no longer recruiting, run by Baylor Research Institute. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06588348, a Early Phase 1 study of Esophagogastric Junction Outflow Obstruction, is active but no longer recruiting, sponsored by Baylor Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
EGJOO is a disorder in which the muscles of the esophagus (swallowing tube) do not function in a coordinated fashion so that swallowed material does not pass easily into the stomach. EGJOO often causes symptoms of swallowing difficulties and chest pain. The cause of EGJOO and its optimal treatment are not clear. The investigators research team suspects that EGJOO might be caused by an allergy that involves the esophagus, and that treatment with medications called corticosteroids might improve function of the esophageal muscles. The purpose of this study is to learn how corticosteroid therapy affects the muscles of the esophagus in patients suffering with EGJOO.
Conditions Studied
Interventions
- OTHER Survey
- DRUG Steroid treatment
- PROCEDURE Esophageal Manometry
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-07-26 |
| Est. Completion | 2026-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06588348
The ClinicalTrials.gov registry entry for NCT06588348 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Esophagogastric Junction Outflow Obstruction appearing as the primary indexed condition, and to 3 interventions - of which Survey is the first listed.
NCT06588348 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06588348 about?
NCT06588348 is a clinical study titled "Corticosteroid Effect on Achalasia Variant EGJOO". EGJOO is a disorder in which the muscles of the esophagus (swallowing tube) do not function in a coordinated fashion so that swallowed material does not pass easily into the stomach. EGJOO often causes symptoms of swallowing difficulties and chest pain. The cause of EGJOO and its optimal treatment a...
What is the current status of trial NCT06588348?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2022-07-26. Estimated completion is 2026-11.
What conditions does trial NCT06588348 study?
This clinical trial studies the following conditions: Esophagogastric Junction Outflow Obstruction.
What interventions are being tested in trial NCT06588348?
The interventions under investigation include: Survey (OTHER), Steroid treatment (DRUG), Esophageal Manometry (PROCEDURE).
Who is sponsoring clinical trial NCT06588348?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588348 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.